0001320271-13-000001.txt : 20130927 0001320271-13-000001.hdr.sgml : 20130927 20130927151916 ACCESSION NUMBER: 0001320271-13-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130916 FILED AS OF DATE: 20130927 DATE AS OF CHANGE: 20130927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: K-V Pharmaceutical Co CENTRAL INDEX KEY: 0000057055 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 430618919 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 BUSINESS PHONE: 3146456600 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: KV PHARMACEUTICAL CO /DE/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stancic Ana CENTRAL INDEX KEY: 0001320271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09601 FILM NUMBER: 131119684 MAIL ADDRESS: STREET 1: CHAMPIONS BIOTECHNOLOGY, INC. STREET 2: 855 NORTH WOLFE STREET, SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-09-16 1 0000057055 K-V Pharmaceutical Co KVA/KVB 0001320271 Stancic Ana CHAMPIONS BIOTECHNOLOGY, INC. 855 NORTH WOLFE STREET, SUITE 619 BALTIMORE MD 21205 1 0 0 0 Option to Purchase 1.62 2013-09-16 4 J 0 10000 0 D 2020-09-07 Class A Common Stock 10000 0 D Option to Purchase 1.14 2013-09-16 4 J 0 7500 0 D 2020-05-24 Class A Common Stock 7500 0 D Option to Purchase 1.49 2013-09-16 4 J 0 20000 0 D 2021-09-08 Class A Common Stock 20000 0 D Option to Purchase 0.94 2013-09-16 4 J 0 20000 0 D 2022-05-14 Class A Common Stock 20000 0 D On September 16, 2013, the Sixth Amended Joint Chapter 11 Plan of Reorganization of K-V Pharmaceutical Company (the "Company"), which was confirmed by the United States Bankruptcy Court for the Southern District of New York on August 28, 2013, was consummated. As a result, all issued and outstanding shares of the Companys Class A Common Stock, Class B Common Stock and 7% Cumulative Convertible Preferred Stock, and the warrants and options exercisable therefor, were cancelled and extinguished. The option was to vest in five equal annual installments beginning on September 7, 2011. The option was to vest in five equal installments beginning on June 24, 2011. The option was to vest in three equal installments beginning on September 8, 2012. The option was to vest 33% on May 14, 2013, 33% on May 14, 2014 and 34% on May 14, 2015. Ana Stancic 2013-09-18